Risk communication committee will meet again
The Risk Communication Advisory Committee will meet April 30 and May 1 to discuss FDA's draft risk communication strategic plan; the panel will be asked for comment and further advice, for example, on strategic priorities for research on effective risk communication. The committee recently recommended that a single patient document be provided to patients in lieu of the current consumer medication guides, patient package inserts and Medication Guides currently handed out at pharmacies
You may also be interested in...
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.